The Relationship Between Osteopontin and Adiponectin in Patients with Essential Hypertension

REFERENCES

• Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993;92:1686–1696.
   PubMed Web of Science ®Google Scholar
• Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994;74:214–224.
   PubMed Web of Science ®Google Scholar
• Liaw L, Lindner V, Schwartz SM, Chambers AF, Giachelli CM. Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 1995;77:665–672.
   PubMed Web of Science ®Google Scholar
• Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin vitro. J Clin Invest 1995;95:713–724.
   PubMed Web of Science ®Google Scholar
• Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 1998; 141:1083–1093.
   PubMed Web of Science ®Google Scholar
• Weintraub AS, Giachelli CM, Krauss RS, Almeida M, Taubman MB. Autocrine secretion of osteopontin by vascular smooth cells regulates their adhesion to collagen gets. Am J Pathol 1996;149:259–272.
   PubMed Web of Science ®Google Scholar
• Campos AH, Zhao Y, Pollman MJ, Gibbons GH. DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: potential mediators of vascular disease. Circ Res 2003;92:111–118.
   PubMed Web of Science ®Google Scholar
• Irita J, Okura T, Kurata M, Miyoshi K, Fukuoka T, Higaki J. Osteopontin in rat renal fibroblasts: Functional properties and transcriptional regulation by aldosterone. Hyper-tension 2008;51:507–513.
   Google Scholar
• Bruemmer D, Collins AR, Noh G, Wang W, Territo M, Arias-Magallona S, Fishbein MC, Blaschke F, Kintscher U, Graf K, Law RE, Hsueh WA. AngiotensinII-accelerated atherosclerosis and aneurysm formation in attenuated in osteopontin-deficient mice. J Clin Invest 2003;112:1318–1331.
   PubMed Web of Science ®Google Scholar
• Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003;170:333–337.
   PubMed Web of Science ®Google Scholar
• Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci 2006;111:319–324.
   PubMed Web of Science ®Google Scholar
• Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006;27:802–807.
   PubMed Web of Science ®Google Scholar
• Irita J, Okura T, Manabe S, Kurata M, Miyoshi K, Watanabe S, Fukuoka T, Higaki J. Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension. Am J Hypertens 2006;19:293–297.
   PubMed Web of Science ®Google Scholar
• Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939–949.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med 2003;228:1111–1117.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adipo-nectin receptors in insulin resistance, diabetes, and the metabolic syndorome. J Clin Invest 2006;116:1784–1792.
   PubMed Web of Science ®Google Scholar
• Haluzik M, Parizkova J, Haluzik MM. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 2004;53:123–129.
   PubMed Web of Science ®Google Scholar
• Ochi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473–2476.
   PubMed Web of Science ®Google Scholar
• Ochi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057–1063.
   PubMed Web of Science ®Google Scholar
• Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002;40:609–611.
   PubMed Web of Science ®Google Scholar
• Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Li J, Williams GH, Adler GK. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008;117:2253–2261.
   PubMed Web of Science ®Google Scholar
• Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, Veglio F, Mulatero P. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 2007; 20:855–861.
   PubMed Web of Science ®Google Scholar
• Blaschke F, Bruemmer D, Yin F, Takata Y, Wang W, Fishbein MC, Okura T, Higaki J, Graf K, Fleck E, Hsueh WA, Law RE. C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 2004;110:579–587.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti- atherosclerosis drugs. Circulation 2001;103:2531–2534.
   PubMed Web of Science ®Google Scholar
• Peng N, Liu JT, Gao DF, Lin R, Li R. AngiotensinII-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 2007;193:292–298.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–1695.
   PubMed Web of Science ®Google Scholar
• Morishita R, Gibbons GH, Tomita N, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: Evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol 2000;20:915–922.
   PubMed Web of Science ®Google Scholar
• Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non- insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645–652.
   PubMed Web of Science ®Google Scholar
• Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM. Aldosterone and Angiotensin II Synergistically Stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 2008;28:1511–1518.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Momiyama Y, Ohmori R, Yonemura A, Ayaori M, Ogura M, Sawada S, Kusuhara M, Nakamura H, Ohsuzu F. Effect of atorvastation on plasma osteopontin levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 2006;26:e129–e130.
   PubMed Web of Science ®Google Scholar
• Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating protein in human atherosclerotic plaques. J Clin Invest 1994; 93: 2393–2402.
   PubMed Web of Science ®Google Scholar
• Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and in a novel comoponent of human atherosclerotic plaques. J Clin Invest 1993;92:1686–1696.
   PubMed Web of Science ®Google Scholar
• Ikead T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human athesosclerosis lesions of the aorta. J Clinvest 1993;92:2814–2820.
   PubMed Web of Science ®Google Scholar
• Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, Diez J, Libby P, Paramo JA. C-reactive protein induces matrix metalloproteinase-1 and -10 in huma endothelial cells: Implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006;47:1369–1378.
   PubMed Web of Science ®Google Scholar
• Krupinski J, Turu MM, Martinez-Gonzalaez J, Carvajal A, Juan-Babot JO, Iborra E, Slevin M, Rubio F, Badimon L. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 2006; 37:1200–1204.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clin Ther 2006;28:1677–1685.
   PubMed Web of Science ®Google Scholar
• Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS. Diurnal and ultradian dynamics of serum adiponectin in healthy men: Comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab 2003;88:2838–2843
   PubMed Web of Science ®Google Scholar